Drugs / Allo-DC-Secretome
Allo-DC-Secretome
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT05261750 | Apr 2022 → Feb 2026 overdue | nasopharyngeal carcinoma | PT. Prodia Stem Cell Indonesia | Active not recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Allo-DC-Secretome | “Treatment with Allo-DC-Secretome 2 cc, and then followed by Auto DC, interval 2 days (via Intramuscular)” NCT05261750 ↗ |
| Known as | Allo-Dendritic Cell-Secretome | “Combination of Auto DC and Allo-Dendritic Cell-Secretome (Allogeneic Dendritic Cell-Secretome as Adjuvant Therapy)” NCT05261750 ↗ |
| Known as | Allogeneic Dendritic Cell-Secretome | “Combination of Auto DC and Allo-Dendritic Cell-Secretome (Allogeneic Dendritic Cell-Secretome as Adjuvant Therapy)” NCT05261750 ↗ |